Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q2 2025 Earnings Call Transcript
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q2 2025 Earnings Call Transcript August 4, 2025Praxis Precision Medicines, Inc. beats earnings expectations.
Praxis Precision Medicines Inc. (PRAX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 1,974,585 | $83,031,299 | +14% | 0.14% |
| 2. | Cormorant Asset Management Bihua Chen | 1,625,000 | $68,331,250 | -7% | 5.09% |
| 3. | Soleus Capital Guy Levy | 966,740 | $40,651,417 | -16% | 2.69% |
| 4. | Point72 Asset Management Steve Cohen | 954,075 | $40,118,854 | +187% | 0.08% |
| 5. | Perceptive Advisors Joseph Edelman | 752,921 | $31,660,328 | -24% | 1.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.75 | 14,500 | $25,375.00 | 14,500 | 2023-10-05 | Filing | |
| $1.06 | 10,000 | $10,587.00 | 45,002 | 2023-06-27 | Filing | |
| $0.87 | 8,000 | $6,997.60 | 46,416 | 2023-03-24 | Filing | |
| $0.86 | 35,002 | $30,206.51 | 35,002 | 2023-03-23 | Filing | |
| $0.86 | 35,000 | $30,159.50 | 226,299 | 2023-03-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.20 | 8,239 | $660,827.46 | 10,301 | 2024-11-14 | Filing | |
| $81.78 | 5,188 | $424,318.34 | 5,613 | 2024-11-14 | Filing | |
| $17.50 | 400,000 | $7,000,000.00 | 0 | 2021-10-06 | Filing | |
| $19.15 | 23,946 | $458,565.90 | 400,000 | 2021-10-05 | Filing | |
| $19.13 | 22,600 | $432,338.00 | 423,946 | 2021-10-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,533,405 | $106,521,598 | 0.05% | |
| 2. | 1,590,128 | $66,864,882 | 0% | |
| 3. | 1,226,339 | $51,567,583 | 0% | |
| 4. | 1,215,644 | $51,117,830 | 0% | |
| 5. | 698,093 | $29,354,811 | 0% |
News See All
Truist Financial Remains Bullish on Praxis Precision Medicines (PRAX)
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is one of the 13 Small Cap Stocks Analysts Are Bullish On.
13 Small Cap Stocks Analysts Are Bullish On
On June 23, Jason Thomas, Carlyle's head of global research and investment strategy, appeared on CNBC’s ‘Squawk Box’ to talk about the state of the market and economy in light of the recent financial...
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript November 6, 2024Praxis Precision Medicines, Inc. beats earnings expectations.
10 Small Cap Stocks with High Potential
As we transition from a tumultuous summer in the financial markets, characterized by rising expectations for interest rate cuts and the consequent impacts on stock and bond performances, investors are...
Hedge Funds Are Piling Into Praxis Precision Medicines, Inc. (PRAX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund and Insider Trading News: Ken Griffin, Ray Dalio, Tiger Global Management, Odey Asset Management, Pfizer Inc. (PFE), Amazon.com, Inc. (AMZN), and More
Citadel Securities told a London court that officials at British hedge fund GSA Capital LLP can’t unsee information taken from a secret algorithm that is at the center of a lawsuit. The U.S.